850340-95-3 Usage
Uses
Used in Pharmaceutical Industry:
1(2H)-Isoquinolinone, 7-fluoro-6-hydroxyis used as an inhibitor for the enzyme human lactate dehydrogenase-A (LDH-A) due to its ability to interfere with cancer metabolism and proliferation. This application is significant in the development of novel therapeutic strategies against various types of cancer.
Additionally, it is used as a potential therapeutic agent for neurologic disorders such as Parkinson's disease, given its pharmacological properties that may contribute to the treatment and management of the condition.
Used in Research and Development:
1(2H)-Isoquinolinone, 7-fluoro-6-hydroxyis utilized as a compound of interest in the field of medicinal chemistry and pharmacology. Its unique structure and properties make it a valuable asset for further research into its potential applications, including the development of new drugs and therapies for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 850340-95-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,0,3,4 and 0 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 850340-95:
(8*8)+(7*5)+(6*0)+(5*3)+(4*4)+(3*0)+(2*9)+(1*5)=153
153 % 10 = 3
So 850340-95-3 is a valid CAS Registry Number.
850340-95-3Relevant academic research and scientific papers
TRICYCLIC SULFONAMIDE DERIVATIVES
-
Paragraph 1048-1050, (2015/07/15)
The invention relates to derivatives of formula (I), wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicament; such derivatives for the treatment of pain.
TRICYCLIC SULFONAMIDE DERIVATIVES
-
Page/Page column 124, (2015/07/16)
The invention relates to derivatives of formula (I), wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicament; such derivatives for the treatment of pain.
SUBSTITUTED ISOQUINOLINONES
-
Page/Page column 44-45, (2010/02/11)
Isoquinolinone compounds are provided that are useful for the inhibition of ADP-platelet aggregation, particularly in the treatment of thrombosis and thrombosis related conditions or disorders.
